%0 Journal Article
%A Margusino-Framinan, Luis
%A Fernandez-Llamazares, Cecilia M.
%A Negro-Vega, Eva
%A Tortajada-Goitia, Begona
%A Lizeaga, Garbine
%A Mercadal-Orfila, Gabriel
%A Almeida-Gonzalez, Carmen
%A Morillo-Verdugo, Ramon
%T Outpatients' Opinion And Experience Regarding Telepharmacy During The COVID-19 Pandemic: The Enopex Project
%D 2021
%@ 1178-2390
%U https://hdl.handle.net/10668/26777
%X Background: Telepharmacy, as a remote pharmaceutical care procedure, is being used worldwide during the COVID-19 pandemic, with the aim of preserving the health of patients and professionals. Its future development should incorporate the assessment of patient perception, but no research study has investigated it.Objective: The objective was to poll the opinions and experiences of outpatients with telepharmacy through a purpose-developed questionnaire and to assess it's quality through an internal validity and reliability analysis.Methods: Cross-sectional observational study of adult patients who used telepharmacy services during the COVID-19 lockdown period in Spain. The subjects answered a 24-item questionnaire, after giving their informed consent. Place of delivery, informed pharmacotherapeutic follow-up, opinion about telepharmacy, future development, ethics/satisfaction, and coordination constituted the six questionnaire categories. After assessing the adequate sample size with the Kaiser-Meyer-Olkin test, the Bartlett sphericity test analyzed the validity of the questionnaire. The intraclass correlation coefficient and Cronbach's alpha coefficient calculations verified the reliability and internal consistency.Results: A total of 9442 interviews were administered to patients from 81 hospitals, of which 8079 were valid (52.8% female). A 54.1% were aged between 41-65 years; 42.7% had been in treatment for more than 5 years; 42.8% lived between 6-31 miles from the hospital. As many as 96.7% of patients were "satisfied" or "very satisfied" with telepharmacy, 97.5% considering it complementary to their usual follow-up; 55.9% expressed a preference for being followed up face to face when visiting the hospital. 75.6% said they had rather receive their medication at home. The sample size obtained was deemed appropriate [the Kaiser-Meyer-Olkin test (0.789) and Bartlett's sphericity test (p
%K telepharmacy
%K coronavirus
%K pharmaceutical care
%K hospital pharmacy service
%K healthcare quality assessment
%K patient reported experience measures
%K Willingness-to-pay
%K Adjusted life year
%K Pharmaceutical care
%K Pharmacy services
%K Telemedicine
%K Implementation
%K Future
%~